ACST Research and Charts

ACST - Acasti Pharma Inc Class A (Healthcare: Biotechnology)

Projected Earnings Date: 2024-09-24 (Delayed quote data 2024-10-25)

Last 3.41	Change ⇑ +0.01 (+0.29%)	Volume 27,692
	Open 3.38	High 3.45	Low 3.20

8EMA (Daily) 3.37	40EMA (Daily) 3.05	50EMA (Daily) 3.00	STO (Daily) 65.752	MACD Hist (Daily) 0.002
8EMA (Weekly) 3.090	40EMA (Weekly) 2.79	50EMA (Weekly) 2.70	STO (Weekly) 88.753	MACD Hist (Weekly) 0.168


Company Profile
Acasti Pharma Inc is a pharmaceutical development company. Its scientific and product development efforts focus on the cardiovascular, central nervous system, and gastrointestinal disorders. Its pipeline products are GTX-104 for Subarachnoid Hemorrhage, GTX-102 for Ataxia-telangiectasia, and GTX-101 for Post Herpetic Neuralgia.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.